Back to search results

Improving Health Literacy in Schizophrenia Spectrum Disorder

This study is looking at how educational sessions can improve understanding and attitudes towards treatment for people with schizophrenia spectrum disorder, schizoaffective disorder, or psychosis. Participants will receive an educational pamphlet about their condition and have a chance to ask doctors questions. Researchers will measure if these sessions improve participants' knowledge about their condition and their attitudes towards treatment. You may be able to join if you are 18-65 years old, have a schizophrenia spectrum disorder diagnosis, are admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit, and are proficient in English. The study aims to enroll 34 participants.

Study design
This is an interventional study involving 34 participants. It will assess knowledge and attitudes before and after educational sessions.
What's involved
You will take tests and complete questionnaires before and after educational sessions. You will also receive educational materials and be able to ask questions. After discharge, you will be called for 12 months to answer questions about medication adherence.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for a total of 12 months after discharge, with calls to answer questions about medication adherence.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07488156

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

Not Yet Recruiting
NAAges 18–65Interventional
Louisiana State University Health Sciences Center in New Orleans
~34 participants
Updated 2026-03-23 on ClinicalTrials.gov
What's tested:Educational sessions

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Post-intervention KAST (Knowledge About Schizophrenia Test) scores
Measured over This will be collected on Day 5 of the study, after the participant has completed both educational sessions.
+1 more outcome measured

Conditions

Schizophrenia Disorder
Schizoaffective Disorder
Psychosis

Explore related trials

PsychosisSchizoaffective DisorderSchizophrenia

Where it's being run

1 sites across 1 states
Louisiana1

Who to contact

Jaudé Petrie, MD
[email protected]
504-702-3000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders
Patients must be proficient in English.
Patients must have a government issued social security number (required for reimbursement through the university).

Exclusion

Patients at UMCNO that are ages 17 or younger
Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions
Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications
Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization
Patients that are not proficient in English
Patients that do not have a government issued social security number

What this trial measures

  • Post-intervention KAST (Knowledge About Schizophrenia Test) scoresThis will be collected on Day 5 of the study, after the participant has completed both educational sessions.

    This includes an 18-item multiple choice test, with only one correct answer for each item. Scores range from 0 to 100%. Higher scores indicate a higher level of knowledge.

  • Post-intervention ATT (Attitudes Toward Treatment) scoresThis will be collected on Day 5 of the study, after the participant has completed both educational sessions.

    This test includes a total of 20 questions, each ranging from 0 to 10 points. Total score ranges from 0 to 200 points. Higher scores indicate a more favorable attitude towards medications.